Premium
Vigabatrin 35 years later — from mechanism of action to benefit–risk considerations
Author(s) -
Shields W. D.,
Pellock J. M.
Publication year - 2011
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.2011.01606.x
Subject(s) - vigabatrin , mechanism of action , action (physics) , medicine , neuroscience , pharmacology , anticonvulsant , psychology , epilepsy , psychiatry , chemistry , biochemistry , physics , quantum mechanics , in vitro
Shields WD, Pellock JM. Vigabatrin 35 years later — from mechanism of action to benefit–risk considerations.
Acta Neurol Scand: 2011: 124 (Suppl. 192): 1–4.
© 2011 John Wiley & Sons A/S.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom